NaCS-PDMDAAC immobilized cultivation of recombinantDictyostelium discoideumfor soluble human Fas ligand production

2014 ◽  
Vol 31 (2) ◽  
pp. 424-430 ◽  
Author(s):  
Chao Zheng ◽  
Xianhai Zeng ◽  
Michael K. Danquah ◽  
Yinghua Lu
Keyword(s):  

2004 ◽  
Vol 11 (1) ◽  
pp. 43-52 ◽  
Author(s):  
Ulrike B. Matter-Reissmann ◽  
Kai-Christian Sonntag ◽  
Urs O. Gilli ◽  
Christian Leguern ◽  
Marten K. J. Schneider ◽  
...  




1995 ◽  
Vol 182 (6) ◽  
pp. 1777-1783 ◽  
Author(s):  
N Kayagaki ◽  
A Kawasaki ◽  
T Ebata ◽  
H Ohmoto ◽  
S Ikeda ◽  
...  

Fas ligand (FasL) is a type II integral membrane protein homologous with tumor necrosis factor (TNF). Recent studies indicate that TNF is processed to yield the soluble cytokine by metalloproteinases at the cell surface of activated macrophages and T cells. In the present study, we investigated whether FasL is also released by metalloproteinases. Treatment with hydroxamic acid inhibitors of matrix metalloproteinases specifically led to accumulation of membrane-type FasL (p40) on the surface of human FasL cDNA transfectants and activated human T cells, as estimated by surface immunofluorescence and immunoprecipitation with newly established anti-human FasL monoclonal antibodies. This surface accumulation of mFasL was associated with the decrease of soluble FasL (p27) in the supernatant as estimated by quantitative ELISA and immunoprecipitation with anti-human FasL monoclonal antibodies. These results indicate that human FasL is efficiently released from the cell surface by metalloproteinases like TNF.



Diabetologia ◽  
2002 ◽  
Vol 45 (1) ◽  
pp. 134-139 ◽  
Author(s):  
R. L. Nolsøe ◽  
O. P. Kristiansen ◽  
Z. M. Larsen ◽  
J. Johannesen ◽  
F. Pociot ◽  
...  


2002 ◽  
Vol 408 (2) ◽  
pp. 155-161 ◽  
Author(s):  
Tracy Vargo-Gogola ◽  
Howard C Crawford ◽  
Barbara Fingleton ◽  
Lynn M Matrisian


2007 ◽  
Vol 29 (6) ◽  
pp. 859-863 ◽  
Author(s):  
Jie Chen ◽  
Yinghua Lu ◽  
Zhinan Xu ◽  
Peilin Cen ◽  
Xiangming Fang


1996 ◽  
Vol 184 (6) ◽  
pp. 2287-2300 ◽  
Author(s):  
Franco Silvestris ◽  
Shigekazu Nagata ◽  
Paola Cafforio ◽  
Nicola Silvestris ◽  
Franco Dammacco

Previous studies have demonstrated that T cell–reactive antibodies in HIV-1 infection contribute to lymphocyte depletion by cytotoxicity that involves differential membrane targets, such as the 43.5-kD receptor on CEM cells. Here, we show that these antibodies bind Fas as result of a molecular mimicry of the gp120. Both flow cytometry and immunoblotting using the human Fas-transfected mouse WC8 lymphoma revealed positive binding of immunoglobulin G from several patients to a 43.8-kD membrane receptor that also reacts with the CH11 anti-Fas monoclonal antibody. Specificity to Fas was further confirmed to chimeric recombinant human Fas-Fc by ELISA, whereas overlapping peptide mapping of a Fas domain (VEINCTR–N) shared by gp120 V3 loop demonstrated a predominant affinity to the full-length 10-mer peptide. Four anti-Fas affinity preparations greatly increased the subdiploid DNA peak of CEM cells similar to agonist ligands of Fas. In addition, anti-Fas immunoglobulin G strongly inhibited the [3H]thymidine uptake of CEM cells in proliferative assays, inducing a suppression as high as provoked by both CH11 mAb and recombinant human Fas ligand. Since anti-Fas were reactive to gp120, it is conceivable that antibodies binding that domain within the V3 region are effective cross-linkers of Fas and increase apoptosis in peripheral T cells. These results suggest that autologous stimulation of the Fas pathway, rather than of lymphocytotoxic antibodies, may aggravate lymphopenia in a number of HIV-1+ subjects.



2004 ◽  
Vol 108 (3) ◽  
pp. 243-251 ◽  
Author(s):  
Yinghua Lu ◽  
Jaco C. Knol ◽  
Maarten H.K. Linskens ◽  
Karl Friehs ◽  
Peter J.M. van Haastert ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document